Not checkedNot checked for notices yet.
A prospective randomized trial of N-acetyl cysteine administration during cold preservation of the donor liver for transplantation
Abdaal W. Khan, Barry J. Fuller, Sudeep R. Shah and 2 more
Annals of Hepatology · 2005
doi:10.1016/s1665-2681(19)32075-7 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Aims: N-acetyl cysteine (NAC), an anti oxidant and a glutathione precursor, is effective in ameliorating liver injury of Tylenol overdose. There is experimental evidence that it also reduces ischemia reperfusion (I/R) injury. This clinical study was undertaken to study the effect of NAC administered in the donor operation.Methods: 22 patients were randomized to receive NAC (IV & Portal flush) or no NAC (Control Group) during donor operation. Peak AST levels and 1-hour postreperfusion biopsies were used to assess I/R injury. Episodes of acute rejection were recorded together with immunosuppressive drug levels.Results: There were 4 exclusions (re-exploration for post-operative hemorrhage x3, OLT for acute liver failure x1). The two groups (n = 9 each) were matched for recipient and donor ages and sex. Viral hepatitis accounted for cirrhosis in 3 patients in NAC Group and 6 patients in Control Group. Statistically, Cold and warm ischemia times were not significantly different as was the use of blood and blood products in both groups. Serum peak AST levels were similar and postreperfusion biopsy showed moderate to severe reperfusion injury in 3 recipients in the NAC Group and 4 in the Control Group. Excluding ones associated with low Tacrolimus levels (n = 4), there were 6 episodes of acute rejection (2-mild, 4-moderate) in the NAC Group and 5 in the Control Group (3-mild,1-moderate, 1-severe).Conclusion: In this pilot study, NAC administered during donor operation did not show a protective effect on I/R injury or on acute cellular rejection.
Abstract licence: CC BY-NC-ND
References41
40 more references, whose wording the paper’s licence keeps private.
All 41 referencesReads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.